Search Results - "Park, Adrian J."

Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively by Neary, Nicola M, Small, Caroline J, Druce, Maralyn R, Park, Adrian J, Ellis, Sandra M, Semjonous, Nina M, Dakin, Catherine L, Filipsson, Karin, Wang, Fang, Kent, Aysha S, Frost, Gary S, Ghatei, Mohammad A, Bloom, Stephen R

“…Peptide YY (PYY) and glucagon like peptide (GLP)-1 are cosecreted from intestinal L cells, and plasma levels of both hormones rise after a meal. Peripheral…”
Get full text

The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones by Meek, Claire L, Lewis, Hannah B, Reimann, Frank, Gribble, Fiona M, Park, Adrian J

“…•Bariatric surgery procedures include gastric banding, sleeve gastrectomy and roux-en-Y gastric bypass.•They are Highlighteffective methods of weight reduction…”
Get full text

Low-dose pancreatic polypeptide inhibits food intake in man by Jesudason, David R., Monteiro, Mariana P., McGowan, Barbara M. C., Neary, Nicola M., Park, Adrian J., Philippou, Elena, Small, Caroline J., Frost, Gary S., Ghatei, Mohammad A., Bloom, Stephen R.

“…Pancreatic polypeptide (PP) is a gut hormone released from the pancreas in response to food ingestion and remains elevated for up to 6 h postprandially. Plasma…”
Get full text

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects : A double-blind, randomized, controlled trial by WYNNE, Katie, PARK, Adrian J, BLOOM, Stephen R, SMALL, Caroline J, PATTERSON, Michael, ELLIS, Sandra M, MURPHY, Kevin G, WREN, Alison M, FROST, Gary S, MEERAN, Karim, GHATEI, Mohammad A

“…This study investigated the effect of subcutaneously administered oxyntomodulin on body weight in healthy overweight and obese volunteers. Participants…”
Get full text

Can encapsulated glutamine increase GLP-1 secretion, improve glucose tolerance, and reduce meal size in healthy volunteers? A randomised, placebo-controlled, cross-over trial by Meek, Claire L, Dr, Reimann, Frank, PhD, Park, Adrian J, PhD, Gribble, Fiona M, Prof

“…Abstract Background Obesity is a global concern and can be effectively treated with bariatric surgery, which is expensive and invasive. Weight loss after…”
Get full text

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats by Dakin, Catherine L, Small, Caroline J, Park, Adrian J, Seth, Asha, Ghatei, Mohammad A, Bloom, Stephen R

“…Oxyntomodulin (OXM) is a product of proglucagon processing in the intestine and the central nervous system. We reported that intracerebroventricular (ICV) and…”
Get more information

Neuroendocrine control of food intake by Park, Adrian J, Bloom, Stephen R

“…PURPOSE OF REVIEWObesity is a major public health problem and substantially increases the risk of type 2 diabetes, hypertension, stroke, cardiovascular,…”
Get full text

Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects by Wynne, Katie, Park, Adrian J., Small, Caroline J., Patterson, Michael, Ellis, Sandra M., Murphy, Kevin G., Wren, Alison M., Frost, Gary S., Meeran, Karim, Ghatei, Mohammad A., Bloom, Stephen R.

“…Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects A Double-Blind, Randomized, Controlled Trial Katie Wynne 1 , Adrian J. Park 1 ,…”
Get full text

Accelerated waning of the humoral response to COVID-19 vaccines in obesity by van der Klaauw, Agatha A., Horner, Emily C., Pereyra-Gerber, Pehuén, Agrawal, Utkarsh, Foster, William S., Spencer, Sarah, Vergese, Bensi, Smith, Miriam, Henning, Elana, Ramsay, Isobel D., Smith, Jack A., Guillaume, Stephane M., Sharpe, Hayley J., Hay, Iain M., Thompson, Sam, Innocentin, Silvia, Booth, Lucy H., Robertson, Chris, McCowan, Colin, Kerr, Steven, Mulroney, Thomas E., O’Reilly, Martin J., Gurugama, Thevinya P., Gurugama, Lihinya P., Rust, Maria A., Ferreira, Alex, Ebrahimi, Soraya, Ceron-Gutierrez, Lourdes, Scotucci, Jacopo, Kronsteiner, Barbara, Dunachie, Susanna J., Klenerman, Paul, Park, Adrian J., Rubino, Francesco, Lamikanra, Abigail A., Stark, Hannah, Kingston, Nathalie, Estcourt, Lise, Harvala, Heli, Roberts, David J., Doffinger, Rainer, Linterman, Michelle A., Matheson, Nicholas J., Sheikh, Aziz, Farooqi, I. Sadaf, Thaventhiran, James E. D.

“…Obesity is associated with an increased risk of severe Coronavirus Disease 2019 (COVID-19) infection and mortality. COVID-19 vaccines reduce the risk of…”
Get full text

Peptide YY sub(3-36) and Glucagon-Like Peptide-1 sub(7-36) Inhibit Food Intake Additively by Neary, Nicola M, Small, Caroline J, Druce, Maralyn R, Park, Adrian J, Ellis, Sandra M, Semjonous, Nina M, Dakin, Catherine L, Filipsson, Karin, Wang, Fang, Kent, Aysha S, Frost, Gary S, Ghatei, Mohammad A, Bloom, Stephen R

“…Peptide YY (PYY) and glucagon like peptide (GLP)-1 are cosecreted from intestinal L cells, and plasma levels of both hormones rise after a meal. Peripheral…”
Get full text